eukaryot
cell
degrad
cytoplasm
constitu
via
proteasom
autophagi
latter
mechan
induc
pathway
capabl
degrad
entir
organel
involv
sequestr
target
within
doublemembran
vesicl
call
autophag
vesicl
autophagosom
follow
fusion
lysosom
enzymat
degrad
vacuolar
content
autophagi
import
respons
cellular
starvat
involv
develop
differenti
remodel
evid
autophagi
import
compon
innat
immun
microbi
invas
nakagawa
colleagu
observ
invas
nonphagocyt
cell
hela
cell
streptococcu
pyogen
follow
bacteri
escap
endosom
cytosol
action
streptolysin
intracytoplasm
bacteri
cell
becam
engulf
within
autophagosom
subsequ
kill
upon
fusion
latter
lysosom
mutant
cell
defici
autophagi
pyogen
instead
multipli
releas
larg
number
viabl
bacteria
cell
autophagi
also
recent
demonstr
play
role
host
defens
tuberculosi
tuberculosi
surviv
within
phagocyt
cell
result
abil
interfer
phagosom
matur
pathway
result
failur
phagosomelysosom
fusion
howev
autophagi
induc
infect
macrophag
nutrient
restrict
ifng
result
reduc
mycobacteri
viabil
action
ifng
independ
reactiv
nitrogen
oxygen
activ
autophagi
also
appear
play
role
defens
intracellular
pathogen
listeria
monocytogen
organ
escap
cytosol
caus
membran
lysi
potenti
greet
autophagosom
thu
cellular
mechan
primari
known
function
autocannib
servic
host
growth
differenti
respons
advers
condit
also
import
compon
innat
system
immun
initi
report
exist
fourth
human
coronaviru
follow
identif
children
respiratori
ill
netherland
esper
colleagu
independ
identifi
appar
coronaviru
detect
respiratori
specimen
ill
children
year
age
whose
respiratori
specimen
yield
neg
direct
fluoresc
antibodi
test
result
influenza
virus
b
parainfluenza
virus
respiratori
syncyti
viru
rsv
adenoviru
studi
perform
new
connecticut
singl
respiratori
ill
season
coronavirusinfect
patient
requir
hospit
meanwhil
bastien
colleagu
detect
respiratori
specimen
patient
canada
fifteen
patient
febril
complain
sore
throat
cough
patient
requir
hospit
infect
patient
rang
age
month
year
median
year
australia
arden
colleagu
detect
specimen
patient
patient
coronaviru
infectional
requir
hospit
admissionrang
age
month
year
one
patient
die
six
patient
coinfect
known
respiratori
pathogen
wheez
observ
ebihara
colleagu
examin
nasopharyng
swab
sampl
obtain
children
year
age
hospit
sapporo
japan
acut
bronchiol
neg
result
test
rsv
influenza
viru
b
human
metapneumoviru
detect
sampl
patient
previous
identifi
coronavirus
known
caus
human
infect
caus
common
cold
sever
acut
respiratori
syndrom
coronaviru
sarscov
although
koch
postul
fulfil
appear
caus
febril
respiratori
tract
infect
individu
age
caus
bronchiol
infant
young
children
mani
infect
date
detect
europ
asia
north
america
australia
rel
sever
indic
appar
frequent
need
hospit
addit
isol
children
kawasaki
diseas
depend
diagnost
criteria
use
approxim
onetenth
almost
threefourth
patient
undergo
ahsct
develop
engraft
syndrom
resembl
acut
graftversushost
diseas
syndrom
consist
fever
skin
rash
occur
time
neutrophil
recoveri
usual
day
transplant
last
median
day
engraft
syndrom
believ
result
cytokin
releas
associ
rapid
engraft
ordinarili
observ
autologousa
oppos
allogeneichematopoiet
stem
cell
transplant
corticosteroid
commonli
use
treatment
patient
engraft
syndrom
although
routin
prophylact
use
corticosteroid
suggest
concern
rais
regard
possibl
result
increas
risk
infecti
complic
mossad
colleagu
cleveland
clinic
ohio
examin
safeti
efficaci
prophylact
corticosteroid
administr
cohort
ahsct
recipi
compar
histor
control
group
patient
receiv
prophylaxi
corticosteroid
corticosteroid
recipi
receiv
methylprednisolon
prednisolon
dose
mgkgday
day
transplant
patient
cohort
receiv
ident
extens
cours
antimicrobi
prophylaxi
five
patient
corticosteroid
prophylaxi
cohort
develop
engraft
syndrom
compar
histor
control
patient
latter
group
die
syndrom
earli
infect
occur
patient
patient
respect
wherea
late
infect
p
p
occur
respect
major
inp
p
fection
group
case
intraven
catheterassoci
bacteremia
three
herpesviru
infect
occur
cohort
invas
fungal
infect
identifi
although
studi
provid
evid
suggest
corticosteroid
prophylaxi
safe
possibl
benefici
prevent
engraft
syndrom
adult
ahsct
recipi
design
shortcom
must
recogn
random
trial
compar
prophylaxi
rapid
recognit
treatment
engraft
syndrom
would
welcom
mutat
gene
affect
pathway
associ
common
phenotyp
manifest
increas
suscept
infect
intracellular
pathogen
particularli
mycobacteria
implic
gene
encod
product
cytokin
cascad
includ
subunit
heterodim
subunit
receptor
subunit
ifng
receptor
critic
element
ifn
signal
transduct
pathway
defici
occur
recess
domin
inherit
pattern
former
usual
result
complet
absenc
cellsurfac
express
result
complet
loss
function
defect
refer
recess
complet
defici
dominantli
inherit
defici
result
truncat
cytoplasm
domain
express
receptor
nonfunct
domin
form
result
reducedbut
total
absentrespons
ifng
refer
domin
partial
defici
median
age
onset
ie
age
first
infect
caus
environment
mycobacterium
patient
recess
complet
defici
year
patient
experienc
infect
per
personyear
observ
die
age
year
patient
domin
partial
defici
contrast
median
age
onset
later
year
infect
occur
onehalf
frequenc
infect
per
personyear
mortal
age
year
patient
recess
complet
defici
like
sever
diseas
shorter
infectionfre
interv
infect
due
rapidli
grow
mycobacteria
observ
commonli
patient
recess
defici
domin
defici
vs
patient
wherea
revers
true
mycobacteri
osteomyel
usual
multifoc
due
mycobacterium
avium
complex
organ
vs
pathogen
mycobacteria
avium
complex
includ
bacil
vaccin
patient
mycobacterium
kansasii
tuberculosi
nonmycobacteri
infect
note
among
patient
caus
salmonella
speci
patient
listeria
monocytogen
patient
human
herpesviru
fatal
kaposi
sarcoma
patient
cytomegaloviru
patient
histoplasma
capsulatum
patient
